Global vaccination at 10x accessability.
At Ensilica, we're eliminating the cold chain and and delivery costs of vaccines, which account for 90% of the total price.
Problem
Pneumonia vaccines are still not completely accessible
90% of the total cost of PCV-13 (targeted pneumonia vaccine) goes towards cold chain delivery and administration. The manufacturing of the vaccine is only $10, but it retails at $220.
-
Environmental factors
Environmental factors such as undernutrition, air pollution, overcrowding, among other external factors create breeding grounds for bacteria and air particles. These stimuli can damage your lungs and can weaken your immune system making people highly prone to Pneumonia.
-
Vaccine Cost
Vaccines are too expensive for some families to afford, with a price of months of work for 5 children.
-
Vaccine storage
The current pneumonia vaccine is to be stored at 2-8 degrees celcius. Because of improper storage, 50% of the vaccines are thrown out, and many don't get to the rural areas.
Ensilication
Reducing vaccine delivery costs (50% of total cost)
Proteins denature (unfold) in room temperatures. We use silica nanoparticle protection around proteins to physically prevent them from unfolding. The outcome of this process, a powder, can be stored at room temperature for 3 years.
Oral vaccination
Lung vaccination through the oral pathway
Following ensilication, the proteins (now in powder form) are compressed into a pill, which then travels to the stomach and releases the proteins at a specific ph level.
The Vision
Hi, we’re Ensilica
We want to create a future where all children have access to life-saving vaccines, that kill 3 million people anually.
Our team
Ensilica was created by two 16 year olds who want to prevent child mortality around the world. We want to make sure that everyone has access to vaccinnes, and developed the Ensilica solution to achieve that.